vaccines
Red Flags In China’s Disease Control
China has made great strides in improving its ability to handle a public health emergency, but problems still linger in disease reporting, writes Dr. Yanzhong Huang.
Sinovac Seeks Approval For H7N9 Vaccine Clinical Trials
Sinovac Biotech has submitted a clinical trial application to commence clinical trials for its vaccine Avian influenza A (H7N9) vaccine.
Takeda To Sell BIKEN’s Chickenpox Vaccine
Takeda has announced a sales agreement with BIKEN to commence the sale of BIKEN's chickenpox vaccine in Japan from February 2014.
Setback For Dengue-Blocking Mosquito Trial In Vietnam
A project to introduce mosquitoes that could potentially block dengue virus on an island off Vietnam has run into an early hurdle.
Alvogen Partially Acquires Lotus Pharma For US$200 Million
Lotus Pharmaceutical has signed a deal with US-based drug maker Alvogen Group Inc, allowing Alvogen to acquire 60 percent of its shares.
H. Pylori Vaccine Shows Promise In Mice
Researchers in China have developed an oral vaccine against H. pylori, the bacteria responsible for some forms of gastric cancer.
Adimmune To Begin Phase III Flu Vaccine Trials In China
Taiwanese vaccine maker Adimmune Corp has received approval from the Chinese government to start Phase III clinical trials of its flu vaccine in China.
A Viral Factory
In the past decade of intensive farming industrialization, a deluge of viral diseases has threatened public health, writes Zaria Gorvett.
Phase 1/2 Results For Takeda’s Norovirus Vaccine
Takeda has announced the results of a Phase 1/2 study of its norovirus vaccine candidate which was found to be well tolerated.
